Diagnostic Testing of STDs Market Size, Trends, Shares, Insights and Forecast – 2020-2027

SEATTLE - Dec. 2, 2020 - PRLog -- Various laboratory diagnostic tests for Sexually Transmitted Diseases (STDs) include, chlamydia diagnostic tests that include, Direct Fluorescent Antibody (DFA), Enzyme immunoassay (EIA).

Statistics:

The global Diagnostic Testing of STDS Market is estimated to account for US$ 290,128.2 Mn in terms of value by the end of 2027.

Global Diagnostic Testing of STDs Market: Drivers

Approval and launch of new diagnostic tests is expected to propel growth of the global diagnostic testing of STDs market over the forecast period.

Global Diagnostic Testing of STDs Market: Opportunities

Increase in STDs awareness is expected to offer lucrative growth opportunities for players in the global diagnostic testing of STDs market. For instance, in March 2020, researchers from Albaha University, Saudi Arabia, reported lack of STDs knowledge among young adults with estimated overall mean of STDs- knowledge scores of 7.95 ± 4.29.

Global Diagnostic Testing of STDs Market: Restraints

Large proportion of STD infected patients in out-of-reach geographic areas is expected to hinder growth of the market. It is observed that a large proportion STD infected patients and related / undetected cases are in out-of-reach geographic areas in many developing regions.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/diagnostic-testing-of-stds-market-3917

Key Takeaways:

Chlamydia segment held dominant position in the global diagnostic testing of STDs market in 2019, accounting for 29.9% share in terms of value. Increasing incidence and prevalence of chlamydia in developing economies is expected to drive the segment growth during the forecast period.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/3917

Market Trends

North America is witnessing increasing adoption of STD testing. For instance, in May 2020, GoodRx, Inc. announced the GoodRx labs marketplace to offer 18 different tests by direct-to-consumer companies such as myLAB Box, Paloma Health and HeyDoctor by GoodRx for conditions such as allergies, coronavirus, diabetes, thyroid, cholesterol, urine analysis, STDs, fertility, and pregnancy.

Global Diagnostic Testing of STDs Market: Key Developments

August 2019: binx health received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its binx io, a molecular point-of-care diagnostic testing platform for the detection of chlamydia and gonorrhea

May 2019: Hologic, Inc. received the U.S. FDA clearance for its Aptima BV and Aptima CV/TV assays used for diagnosing vaginitis

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/3917